Evonik Industries (EVK) Given a €19.00 Price Target at HSBC

HSBC set a €19.00 ($22.09) target price on Evonik Industries (FRA:EVK) in a research report sent to investors on Thursday morning. The firm currently has a sell rating on the stock.

A number of other equities analysts have also recently weighed in on EVK. Macquarie set a €27.00 ($31.40) price objective on shares of Evonik Industries and gave the stock a neutral rating in a research report on Thursday, November 29th. JPMorgan Chase & Co. set a €27.00 ($31.40) price objective on shares of Evonik Industries and gave the stock a sell rating in a research report on Monday, September 17th. Morgan Stanley set a €35.00 ($40.70) price objective on shares of Evonik Industries and gave the stock a buy rating in a research report on Tuesday. Deutsche Bank set a €40.00 ($46.51) price objective on shares of Evonik Industries and gave the stock a buy rating in a research report on Monday, December 3rd. Finally, Societe Generale set a €40.00 ($46.51) price objective on shares of Evonik Industries and gave the stock a buy rating in a research report on Tuesday, November 6th. Five equities research analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of €32.66 ($37.98).

FRA:EVK traded down €0.21 ($0.24) during trading hours on Thursday, reaching €22.62 ($26.30). 259,968 shares of the company were exchanged. Evonik Industries has a twelve month low of €26.78 ($31.14) and a twelve month high of €32.97 ($38.34).

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Further Reading: Day Trading – Risk Worth the Reward?

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply